Speaker illustration

Doctor Ingeborg Friehs

Boston Children's Hospital, Boston (United States of America)

Dapagliflozin prevents fibrogenic activation in endocardial endothelial cells under altered flow

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Adult congenital heart disease: medical treatment

Thumbnail

ESC 365 is supported by